Stay updated on Influenza Vaccine Reactogenicity in Younger and Older Adults Clinical Trial

Sign up to get notified when there's something new on the Influenza Vaccine Reactogenicity in Younger and Older Adults Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Influenza Vaccine Reactogenicity in Younger and Older Adults Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    Added a Publications section with a PubMed-cited article about the study’s vaccine safety and immunogenicity (Hum Vaccin Immunother, 2026;22(1):2631804) and a 'From PubMed' note.
    Difference
    0.2%
    Check dated 2026-02-26T10:45:59.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.4.2 as the current version, replacing Revision: v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-12T02:31:20.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    Revision updated from v3.4.0 to v3.4.1.
    Difference
    0.0%
    Check dated 2026-02-05T00:27:36.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    Non-substantive UI changes include the glossary toggle label (Show glossary), capitalization tweaks in the Last Update Submitted and No FEAR Act text, and a revision/version update from v3.3.4 to v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T21:44:52.000Z thumbnail image
  7. Check
    55 days ago
    Change Detected
    Summary
    Revision: v3.3.4 replaces the previous v3.3.3 in the page header.
    Difference
    0.0%
    Check dated 2026-01-14T04:05:50.000Z thumbnail image
  8. Check
    77 days ago
    Change Detected
    Summary
    Locations section updated to include Nova Scotia and Quebec as study sites, with corresponding Nova Scotia and Quebec Location blocks removed. Page revision updated from v3.3.2 to v3.3.3, and the HHS Vulnerability Disclosure link was removed from the footer.
    Difference
    0.3%
    Check dated 2025-12-23T20:16:43.000Z thumbnail image

Stay in the know with updates to Influenza Vaccine Reactogenicity in Younger and Older Adults Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Influenza Vaccine Reactogenicity in Younger and Older Adults Clinical Trial page.